Lybrate.com has an excellent community of Oncologists in India. You will find Oncologists with more than 27 years of experience on Lybrate.com. You can find Oncologists online in Chennai and from across India. View the profile of medical specialists and their reviews from other patients to make an informed decision.
Book Clinic Appointment
Submit a review for Dr. R. PichammalYour feedback matters!
About my wife back pain started in her lumber and thoracic back portion in the month of feb. 2012. We started treatment under local doctor's advice and took pain killers and some muscle relaxant and pain healed. But, it got repeated every week and we did the same treatment for the span of month. After that we did total analysis and it was found that there is compression at d8-d-9 and infection from d8-d10 and l3-l4 of spine. Then we did biopsy (first biopsy) of developed lesions and all reports were normal. At this time othopedician doctor advise us that it can be non-detectable tb infection (as it is non-pulmonary) and we started akt-4 on the basis of symptoms even though mtb was negative up to 4th week of culture growth. She took akt-4 for 20 months (june 2012 to feb-2014). During last 6 months of this time of period she was absolutely fine and started normal movements which were restricted during initial part of treatment. Infection was healed partially, and lesions was also started to disappear. We monitored it by ct scan after every 3 months. But in dec 2014 when medicine supposed to stop completely, again sever back pain started and it was found that there is formation of pus and damage of tissues at d8-d10, l3-l4. During this time of period she suddenly lost her weight by 18 kg (within 15 days), so operated and currated all the pus and infected part from the infected location (second biopsy). That sample we again sent for all the lab tests and it is again negative for mtb. We cultured that sample further and it is fount that this is slow growing ntm (non tuberculin mycobacterium) infection. And rest of all test were normal. As it is very slow growing we cannot found out exact genome of that bacterium. So, at this time infectious disease specialist and spine specialist doctors took decision together and stop akt 4 and started her; 1. Amikacin sulphate 1g: daily im/iv 2. Clarrithromycin: 500mg twice a day 3. Doxycyclin and lactic acid bacillus: twice a day 4. Levofloxacin: 750mg once a day during this treatment only her bsl found high without any diabetic history; so she is also taking, 5. Reclide 80mg twice a day 6. Metformine 500 mg twice a day as amikacin daily 1 gm is very high dose we are monitoring her serum creatinine, lft, esr, crp level on weekly basis; and if serum creatinine level is above standard value doctor advising to stop amikacin for some time and once it comes to normal level again we are starting it. Rests of the medicines are same. Above mentioned medicine has been taken for 4.5 months and again we did contrast mri for analyzing effectiveness of therapy. But in this latest mri report it is found that there is new disease has been developed at d9-d10 vertebral bodies and intervention disc. So, we taken advice from Dr. Rajeev soman, hinduja, mumbai. He has diagnosed it as below; 1. Primary tuberculine infection 2. Secondary nosocomial infection 3. Non-tubeculine mycobacterium and prescribed following medicines for 6 months; 1. Inj. Tigecycline (tiganex) 50 mg, bd - 6 months 2. Tab. Clarrithromycine (synclar) 500 mg, bd - 6 months 3. Tab. Levofloxacine (levoflox) 750 mg, od - 6 months 4. Tab. Linezolid 600 mg, od - 6 months } now all medicines stopped due to severe side effect. Side effect recovery is going on. What should we do?
Ovaries are the primary reproductive organs in the female body which produces the eggs that need to be fertilized to form a fetus in the womb. Ovarian cancer is a type of cancer that develops in the ovaries and spreads till the pelvis and the abdomen. This cancer is usually cured by either a surgery or chemotherapy.
Ovarian cancer is mostly caused due to a genetic mutation which transforms the healthy cells of the ovaries into abnormal cancerous cells. The abnormal cells then generally form a tumor which spreads further inside the female body. The type of cell in which the cancer begins determines the type of ovarian cancer you have. Ovarian cancer types include:
- Epithelial tumors: it is the most common type of ovarian cancer which begins from the thin layer that covers the ovaries.
- Stromal tumors: this type begins in those tissues which contain the hormone producing cells.
- Germ cell tumors: this usually happens among relatively younger women, and it originates from the egg producing cells of the ovaries.
Factors that boost your risk of getting an ovarian cancer are listed below:
- Age: the risk of ovarian cancer is greater in women who are between 50 to 60 years. However, ovarian cancer is such a condition that can occur at any age.
- Estrogen hormone replacement therapy: this therapy tends to alleviate menopausal symptoms and renews the hormones of a woman's body. If you are undergoing this therapy then you are at a risk of developing ovarian cancer.
- Congenital: the risk of ovarian cancer can sometimes also be due to an inherited gene mutation and can be passed on from the parents to the offspring.
- Menstrual risk: if you had started menstruating before the age of 12 or had a menopause before the age of 52 then the risk of you developing ovarian cancer increases.
- Other risk factors: these factors do not pose a subsequent amount of threat of having an ovarian cancer, but they slightly increase the risk. These are activities like: regular smoking, fertility treatments, never being pregnant, use of an intrauterine device and polycystic ovary syndrome.
Is it possible to have esophageal cancer without GERD or Barrett's esophagus? How long does normal esophagus turn to GERD to Barrett's esophagus to cancer?
I am 27 years old married lady. I have big breasts and I am uncomfortable with it. Kindly suggest a safe way.
I would like to know if a person have died due to cancer than is there any chance that it might be diagnosed in future in his son/daughter. If yes than Is there any precautionary medicine for such invention for eg. As for some disease we take some precautionary injunction so it does not occur in future.
Hello doctor, I am having a burning or may be acidity from my stomach to my throat and sometimes in my chest, sometimes when I breath deep I feel someone is stretching my veins in my chest, and I feel some kind of lumps is there in my throat, I am having this for 4 days. I use to smoke a little, but was a heavy smoker for 3 years like 10 cigarettes on an average in past but now 1 or 2 on a daily basis, should I be worried of cancer or something, am nervous and can't sleep please help me out doctor. Thanks a lot in advance.
What is the treatment for prostrate. Remedial steps to prevent prostrate. Food habits to be adopted. Medicine for prostrate.
I have red itchy pimples on my both breasts. It occurs twice a week. Is this some kind of cancer. Tell me.
I am a student of 12 class and my problem is I found some stone like hard material inside my breast it does not create any pain its size is approx 3 cm. What is this how can I cure this I am very about that? Is it take surgery?
Age 56. How to prevent prostrate from enlarging? psa count normal. Urine flow test normal so far. Ultrasound indicates enlarged prostrate. Is there a preventive method to stop prostrate enlargement?
A 62 year old Patient is diagnosed with prostate cancer affecting backbone and hip bone, what will be the line of treatment if patient doesn't want to have biopsy done.
Usg thyroid impression: 1. Bilateral heterogeneous sols, of concerning for suspicious nature.(suggested fnac) 2. Prominent lymph nodes bilaterally. Please help.
I am 19 years old female. I have lump on my left breast and also right breast. Sized 2.5cm. After doing fnac needle test it shows its fibroadenoma? is it safe? can I leave as it is? or should I operate it? if so when can I operate it? after operated will I get any problem?
New research on urinary and sexual outcomes could eventually help prostate cancer patients decide on their course of treatment.
“The ultimate goal is to develop a predictive tool that lets patients decide which treatment is right for them based on the symptoms they have beforehand, and their tolerance for any change – even temporary – in those symptoms,” said researcher Matthew Johnson, MD in a press release. Dr. Johnson is a resident physician in the Department of Radiation Oncology at Fox Chase Cancer Center in Philadelphia, Pennsylvania, USA.
Dr. Johnson and his colleagues presented their study findings in September at the American Society for Radiation Oncology’s 56th Annual Meeting.
Their data came from two study groups of men with prostate cancer who received one of four treatments: intensity modulated radiation therapy (IMRT), low dose rate brachytherapy (LDR), post-prostatectomy IMRT (PPRT), or radical prostatectomy (RP).
Using questionnaires, the researchers assessed the men’s symptoms at baseline and after treatment.
One group of 3,515 men completed the American Urological Association Symptom Score, designed to evaluate urinary symptoms. Over 14,500 surveys were completed. Lower scores on this tool indicate better urinary function. This group was followed for a median of 28 months.
For patients who received IMRT, follow-up scores were slightly lower than baseline. PPRT patients had similar results. LDR patients tended to see an initial score increase when compared to IMRT patients, but fell back to comparable levels after 34 months. Men who underwent RP had lower scores at baseline and after treatment.
The Sexual Health Inventory for Men (SHIM) questionnaire was used to evaluate sexual symptoms in a group of 857 men who completed more than 2,600 surveys. Higher SHIM scores are associated with better sexual function. The median follow-up time was 18 months.
The scores of men who were treated with LDR and PPRT were not much different from those treated with IMRT. However, men who had had RP had the largest score decreases between baseline and follow-up.
These results could help clinicians counsel patients with prostate cancer, the authors noted. In this way, patients could have a better idea of what to expect in terms of urinary and sexual symptoms.
American Society for Radiation Oncology (ASTRO)
Johnson, M.E., et al.
“A Comparison of Urinary and Sexual Function Patient Reported Outcomes (PROs) Among Treatment Modalities for Prostate Cancer (PCa)”
(Abstract presented at ASTRO’s 56th Annual Meeting. September 16, 2014. Presentation #180)
Fox Chase Cancer Center
“Fox Chase Study Helps Identify When and How Much Various Prostate Cancer Treatments will Impact Urinary and Sexual Functioning”
(News release. September 16, 2014)
- See more at: http://www.issm.info/news/sex-health-headlines/prostate-cancer-treatments-and-urinary-sexual-functioning#sthash.Tym9DcEt.dpuf